Search

everythinglearnresearchcommunity

for

Search:↓

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

Isotretinoin's effects and side effects, like birth defects and depression, might be due to it causing cell death in various cells.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

People with myotonic dystrophy type 1 tend to develop basal cell carcinoma at a younger age but not more frequently than others.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Nutrease powder, a high-protein, low-carb supplement, can help manage Polycystic Ovary Syndrome symptoms, regulate periods, improve ovulation, and restore fertility.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Women with PCOS, especially if they are obese, are more likely to have an underactive thyroid than women without PCOS.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.